Wall Street analysts expect HCA Healthcare Inc (NYSE:HCA) to post sales of $12.16 billion for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for HCA Healthcare’s earnings, with estimates ranging from $12.04 billion to $12.35 billion. HCA Healthcare posted sales of $11.56 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 5.2%. The business is expected to report its next quarterly earnings results on Tuesday, January 29th.

According to Zacks, analysts expect that HCA Healthcare will report full year sales of $46.53 billion for the current financial year, with estimates ranging from $46.20 billion to $46.76 billion. For the next year, analysts expect that the firm will report sales of $49.52 billion, with estimates ranging from $48.59 billion to $50.67 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. The business had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.13 earnings per share.

Several analysts recently commented on the stock. Credit Suisse Group raised their price target on shares of HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a research report on Thursday, November 1st. Jefferies Financial Group raised their price target on shares of HCA Healthcare to $155.00 and gave the company a “buy” rating in a research report on Friday, September 21st. SunTrust Banks lifted their target price on shares of HCA Healthcare to $150.00 and gave the company a “positive” rating in a research report on Tuesday, September 4th. Morgan Stanley lifted their target price on shares of HCA Healthcare from $115.00 to $124.00 and gave the company an “underweight” rating in a research report on Wednesday, September 5th. Finally, Zacks Investment Research lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, November 27th. Two analysts have rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. HCA Healthcare has an average rating of “Buy” and a consensus price target of $144.15.

Shares of NYSE HCA traded down $4.99 during midday trading on Wednesday, reaching $135.86. The company had a trading volume of 1,801,284 shares, compared to its average volume of 1,788,475. The stock has a market cap of $48.48 billion, a P/E ratio of 20.62, a P/E/G ratio of 1.24 and a beta of 0.52. HCA Healthcare has a 1 year low of $84.13 and a 1 year high of $147.42.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be given a dividend of $0.35 per share. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 1.03%. HCA Healthcare’s payout ratio is presently 21.24%.

In related news, SVP Kathryn A. Torres sold 820 shares of the business’s stock in a transaction dated Tuesday, November 13th. The shares were sold at an average price of $142.36, for a total transaction of $116,735.20. Following the transaction, the senior vice president now directly owns 4,237 shares in the company, valued at $603,179.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Deborah M. Reiner sold 723 shares of the business’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $135.06, for a total transaction of $97,648.38. Following the transaction, the senior vice president now owns 6,184 shares in the company, valued at $835,211.04. The disclosure for this sale can be found here. Insiders have sold 16,763 shares of company stock worth $2,346,147 over the last 90 days. 2.80% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of HCA. Signet Financial Management LLC purchased a new position in HCA Healthcare during the second quarter worth about $137,000. Rehmann Capital Advisory Group raised its stake in shares of HCA Healthcare by 12,665.9% in the 3rd quarter. Rehmann Capital Advisory Group now owns 21,702 shares of the company’s stock valued at $156,000 after acquiring an additional 21,532 shares during the period. Adviser Investments LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $159,000. Bamco Inc. NY purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $169,000. Finally, Bridgeworth LLC acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $173,000. Hedge funds and other institutional investors own 69.94% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: The Discount Rate – What You Need to Know

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.